Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-025279
Filing Date
2022-04-22
Accepted
2022-04-22 12:31:55
Documents
1
Period of Report
2022-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6088
  Complete submission text file 0001209191-22-025279.txt   7377
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
Ray Amrit (Reporting) CIK: 0001924797 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 22844590